article thumbnail

Examining Current Challenges in Parenteral Nutrition Compounding

Drug Topics

Compounding parenteral nutrition solutions is a complex process with a high risk for error, which can lead to serious adverse outcomes.

article thumbnail

The Importance of Continuing Education in Pharmacy Compounding

Drug Topics

Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clearmind licenses psychedelic compounds for mental disorders

Pharmaceutical Technology

psychedelic compounds for mental disorders. Clearmind Medicine has entered into a licensing agreement with Yissum to develop Generation 3.0

article thumbnail

Significant strides made in Nxera Pharma's oral compound for neurological conditions

Outsourcing Pharma

has initiated its phase 1 clinical study, marking a significant stride in the evaluation of NBI-1117567, an investigational small molecule, oral compound developed by Nxera Pharma. Neurocrine Biosciences Inc.

article thumbnail

The History of Pharmaceutical Compounding

Compounding Pharmacy of America

The history and evolution of compounding medications goes back several decades, and over time, the practice has become more beneficial for patients. The post The History of Pharmaceutical Compounding appeared first on The Compounding Pharmacy of America.

article thumbnail

Preserving Patient Access to Compounded Medications Act of 2017

Pharmacy Times

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.

article thumbnail

Novo Nordisk settles with 2 Florida sellers of compounded Ozempic

Fierce Pharma

Novo Nordisk has reached confidential settlements with two Florida sellers of compounded versions of the mega-blockbuster semaglutide treatments Ozempic and Wegovy, the company said on Friday.